Approval · Notice of Compliance 14051 · 2013
PICATO: Notice of Compliance 14051
Issued January 30, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14051
- Date
- January 30, 2013
- Company
- Leo Pharma IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Chemoptherapeutic for topical use (d06bx02)
Products in this notice
Medicinal ingredients
- INGENOL MEBUTATE 0.015 PER
- INGENOL MEBUTATE 0.05 PER